Menu
Currency
GWAS Study

Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction.

Jia G, Ping J, Guo X et al.

38741014 PubMed ID
GWAS Study Type
40138 Participants
168 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

JG
Jia G
PJ
Ping J
GX
Guo X
YY
Yang Y
TR
Tao R
LB
Li B
AS
Ambs S
BM
Barnard ME
CY
Chen Y
GM
Garcia-Closas M
GJ
Gu J
HJ
Hu JJ
HD
Huo D
JE
John EM
LC
Li CI
LJ
Li JL
NK
Nathanson KL
NB
Nemesure B
OO
Olopade OI
PT
Pal T
PM
Press MF
SM
Sanderson M
SD
Sandler DP
SX
Shu XO
TM
Troester MA
YS
Yao S
AP
Adejumo PO
AT
Ahearn T
BA
Brewster AM
HA
Hennis AJM
MT
Makumbi T
NP
Ndom P
OK
O'Brien KM
OA
Olshan AF
OM
Oluwasanu MM
RS
Reid S
BE
Butler EN
HM
Huang M
NA
Ntekim A
QH
Qian H
ZH
Zhang H
AC
Ambrosone CB
CQ
Cai Q
LJ
Long J
PJ
Palmer JR
HC
Haiman CA
ZW
Zheng W
Chapter II

Abstract

Summary of the research findings

We performed genome-wide association studies of breast cancer including 18,034 cases and 22,104 controls of African ancestry. Genetic variants at 12 loci were associated with breast cancer risk (P < 5 × 10-8), including associations of a low-frequency missense variant rs61751053 in ARHGEF38 with overall breast cancer (odds ratio (OR) = 1.48) and a common variant rs76664032 at chromosome 2q14.2 with triple-negative breast cancer (TNBC) (OR = 1.30). Approximately 15.4% of cases with TNBC carried six risk alleles in three genome-wide association study-identified TNBC risk variants, with an OR of 4.21 (95% confidence interval = 2.66-7.03) compared with those carrying fewer than two risk alleles. A polygenic risk score (PRS) showed an area under the receiver operating characteristic curve of 0.60 for the prediction of breast cancer risk, which outperformed PRS derived using data from females of European ancestry. Our study markedly increases the population diversity in genetic studies for breast cancer and demonstrates the utility of PRS for risk prediction in females of African ancestry.

18,034 African or African American cases, 22,104 African or African American controls

Chapter III

Study Statistics

Key metrics and study information

40138
Total Participants
GWAS
Study Type
No
Replicated
African American or Afro-Caribbean, Sub-Saharan African, African unspecified
Ancestry
Cameroon, U.S., Barbados, Uganda, Ghana, Nigeria
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.